Correspondence 0001493152-23-026411 from INVO Fertility, Inc. (IVF)
INVO Fertility, Inc.
Date: Aug. 2, 2023 · CIK: 0001417926 · Accession: 0001493152-23-026411
AI Filing Summary & Sentiment
File numbers found in text: 333-273174
Letter
Re: INVO Bioscience, Inc.
August 2, 2023
Securities and Exchange Commission
F. Street, NE
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-273174
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC, as placement agent, hereby joins the request of the Company that the effective date of the above-captioned Registration Statement be accelerated so as to permit it to become effective on Thursday, August 3, 2023, at 5:30 p.m., ET, or as soon thereafter as practicable.
MAXIM GROUP LLC
By: /s/ Clifford A. Teller
Name: Clifford A. Teller
Title: Co-President
Show Raw Text
CORRESP
1
filename1.htm
August
2, 2023
Securities
and Exchange Commission
100
F. Street, NE
Washington,
D.C. 20549
Re:
INVO
Bioscience, Inc.
Registration
Statement on Form S-1
File
No. 333-273174
VIA
EDGAR
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as
amended, Maxim Group LLC, as placement agent, hereby joins the request of the Company that the effective date of the above-captioned
Registration Statement be accelerated so as to permit it to become effective on Thursday, August 3, 2023, at 5:30 p.m., ET, or as soon
thereafter as practicable.
MAXIM
GROUP LLC
By:
/s/
Clifford A. Teller
Name:
Clifford A. Teller
Title:
Co-President